More about

Cutaneous Squamous Cell Carcinoma

News
November 11, 2023
1 min read
Save

Extensive perineural invasion may be optimal prognostic measure for poor CSCC outcomes

Extensive perineural invasion may be optimal prognostic measure for poor CSCC outcomes

Extensive perineural invasion may be the optimal prognostic measure of perineural invasion and poor cutaneous squamous cell carcinoma outcomes, according to a study.

News
May 30, 2023
1 min read
Save

Almirall partners with Centre for Genomic Regulation for advancements in skin cancer

Almirall partners with Centre for Genomic Regulation for advancements in skin cancer

Almirall and the Centre for Genomic Regulation have entered into a research collaboration to develop and characterize novel preclinical models for the identification of new nonmelanoma skin cancer treatments, according to a press release.

News
March 24, 2023
3 min watch
Save

VIDEO: Gene expression algorithm helps identify basal cell carcinoma biomarkers

VIDEO: Gene expression algorithm helps identify basal cell carcinoma biomarkers

NEW ORLEANS — A machine learning algorithm was able to differentiate between basal cell and squamous cell carcinomas by identifying biomarkers, according to a poster presented here.

News
March 02, 2023
1 min read
Save

Oral nicotinamide ineffective in preventing keratinocyte cancers

Oral nicotinamide ineffective in preventing keratinocyte cancers

Nicotinamide therapy was not effective in lowering the rates of keratinocyte cancers or actinic keratoses in immunosuppressed solid-organ transplant recipients, according to a phase 3 trial.

CME
Multimedia

Immunotherapy in NMSC: Challenges in CSCC and BCC

Immunotherapy in NMSC: Challenges in CSCC and BCC
0.25 CME
0.25 CNE
15 MINS
$0 FEE
News
January 03, 2023
3 min read
Save

Most read cutaneous oncology articles of 2022

Most read cutaneous oncology articles of 2022

Healio has compiled a top 10 list of its most read articles related to cutaneous oncology in 2022.

CME
Multimedia

Immunotherapy in NMSC: Bringing the Data to Life

Immunotherapy in NMSC: Bringing the Data to Life
0.50 CME
0.50 CNE
30 MINS
$0 FEE
News
September 25, 2022
1 min read
Save

ESMO presentations highlight advances in kidney cancer, melanoma, lung cancer

ESMO presentations highlight advances in kidney cancer, melanoma, lung cancer

This year’s European Society for Medical Oncology Congress featured potentially practice-changing research in kidney cancer, cutaneous squamous cell carcinoma, lung cancer and melanoma.

News
July 06, 2021
1 min read
Save

FDA approves Keytruda for locally advanced cutaneous squamous cell carcinoma

FDA approves Keytruda for locally advanced cutaneous squamous cell carcinoma

The FDA expanded the approval of pembrolizumab to include treatment of patients with locally advanced cutaneous squamous cell carcinoma not curable by surgery or radiation, according to the agent’s manufacturer.

News
January 19, 2021
1 min read
Save

FDA grants fast track designation to AST-008 for skin cancer indications

FDA grants fast track designation to AST-008 for skin cancer indications

The FDA granted fast track designation to cavrotolimod for two skin cancer indications, according to the agent’s manufacturer.

View more